Recent Price Movement and Market Context
On 29 Dec 2025, Entero Healthcare Solutions recorded its lowest price ever at Rs.944. This follows a two-day consecutive decline, with the stock posting a cumulative return of -1.6% over this period. The one-day performance registered a marginal fall of 0.12%, contrasting with the Sensex’s modest gain of 0.10% on the same day. Over the past week, the stock’s return stood at -1.88%, compared to the Sensex’s -0.51% movement.
More pronounced is the stock’s trajectory over longer time frames. The one-month return shows a decline of 10.55%, while the three-month period reflects an 11.38% fall. These figures stand in stark contrast to the Sensex, which posted gains of 5.93% over three months and modest declines over shorter intervals. The year-to-date performance of Entero Healthcare Solutions is marked by a 32.63% reduction in value, whereas the Sensex has advanced by 8.95% during the same timeframe.
Over the last year, the stock’s return was recorded at -33.11%, a significant divergence from the Sensex’s 8.17% appreciation. The three- and five-year returns for Entero Healthcare Solutions remain at zero, indicating a lack of appreciable growth over these periods, while the Sensex has delivered 39.25% and 78.79% respectively. The ten-year return for the stock also remains at zero, compared to the Sensex’s 226.42% increase.
Technical Indicators and Trading Patterns
Entero Healthcare Solutions is currently trading below all major moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning suggests a persistent downward momentum in the stock price. The stock’s performance today aligns closely with the retailing sector’s overall movement, indicating sector-wide influences may be at play alongside company-specific factors.
Built for the long haul! Consecutive quarters of strong growth landed this Small Cap from Chemicals on our Reliable Performers list. Sustainable gains are clearly ahead!
- - Long-term growth stock
- - Multi-quarter performance
- - Sustainable gains ahead
Financial Performance and Growth Metrics
Despite the stock’s subdued market performance, Entero Healthcare Solutions has demonstrated notable growth in its financial results. The company’s net sales have expanded at an annual rate of 30.10%, reflecting a healthy top-line trajectory. Operating profit has shown a substantial rise, with a growth rate of 127.38%, indicating improved operational efficiency over time.
Quarterly results reveal that net sales reached a peak of Rs.1,570.95 crore, while PBDIT (Profit Before Depreciation, Interest and Taxes) attained a high of Rs.62.06 crore. The operating profit margin relative to net sales also hit a quarterly high of 3.95%, signalling enhanced profitability within the retailing segment.
The company has reported positive results for seven consecutive quarters, underscoring a consistent pattern of financial advancement despite the stock’s price challenges.
Valuation and Capital Structure
Entero Healthcare Solutions exhibits a Return on Capital Employed (ROCE) of 8.6%, which is considered attractive within its sector. The enterprise value to capital employed ratio stands at 2.2, suggesting a valuation discount relative to its peers’ historical averages. This valuation context may reflect market caution amid the stock’s recent price movements.
The company’s debt servicing capacity appears robust, with a Debt to EBITDA ratio of 1.33 times. This level indicates manageable leverage and a capacity to meet financial obligations without undue strain.
Shareholding and Market Position
Institutional investors hold a significant stake in Entero Healthcare Solutions, accounting for 24.32% of the shareholding. This level of institutional participation suggests a degree of confidence in the company’s fundamentals from investors with extensive analytical resources.
Holding Entero Healthcare Solutions from Retailing? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Comparative Performance and Sectoral Context
When compared to the broader BSE500 index, Entero Healthcare Solutions has underperformed over multiple time horizons including the last three months, one year, and three years. This trend highlights the stock’s relative weakness within the retailing sector and the wider market.
While the Sensex and other benchmarks have delivered positive returns over the medium to long term, Entero Healthcare Solutions has not recorded appreciable gains over three, five, or ten years, with returns remaining at zero. This contrast emphasises the stock’s subdued market trajectory despite underlying growth in sales and profits.
The Price/Earnings to Growth (PEG) ratio of the company stands at 0.3, reflecting the relationship between its earnings growth and valuation metrics.
Summary of Current Situation
Entero Healthcare Solutions’ stock price reaching an all-time low of Rs.944 is a significant event that encapsulates a period of sustained price pressure. The stock’s performance over recent months and years has lagged behind key market indices and sector averages. Despite this, the company’s financial statements reveal steady growth in sales and profitability, alongside a manageable debt profile and attractive valuation ratios.
The divergence between the company’s operational results and its market valuation underscores the complex dynamics influencing investor sentiment and stock price movements within the retailing sector.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Today
